Health Condition 1: I10- Essential (primary) hypertension
Conditions
Interventions
Intervention1: UJJAYI PRANAYAMA: PROCEDURE:
Sit in any comfortable meditative asana.
Close the eyes and relax the whole body.
Take the awareness to the breath in the nostrils and allow the breathing t
Sponsors
Dr Govindan P
Eligibility
Inclusion criteria
Inclusion criteria: Adults aged 30 to 65 years, of either sex. Clinically diagnosed primary (essential) hypertension, defined as: Systolic Blood Pressure more than 140 mmHg and or Diastolic Blood Pressure more than 90 mmHg, measured on at least two occasions, or individuals receiving stable antihypertensive medication for at least 4 weeks. Resting blood pressure at screening less than or equal to 180/110 mmHg. Individuals willing and able to participate in the study and comply with study procedures, including sitting quietly and performing guided breathing for 15 minutes. Participants not practicing yoga, pranayama, meditation, or any structured breathing techniques regularly in the preceding 3 months. Stable clinical condition without any acute illness at the time of enrollment. Ability to understand the study procedures and provide written informed consent.
Exclusion criteria
Exclusion criteria: Secondary hypertension, including renal, endocrine, or drug-induced causes. Severe or uncontrolled hypertension, defined as: Systolic BP more than 180 mmHg and or Diastolic more than BP 110 mmHg. History or evidence of major cardiovascular disease, including: Coronary artery disease or previous myocardial infarction Heart failure Significant valvular heart disease Clinically significant cardiac arrhythmias Diabetes mellitus with autonomic neuropathy or poorly controlled diabetes HbA1c more than 8.5 percent. Known autonomic nervous system disorders or neurological conditions affecting autonomic regulation. Chronic respiratory disorders that may interfere with breathing practices, such as: Bronchial asthma requiring regular medication Chronic obstructive pulmonary disease (COPD) Chronic kidney disease (Stage 3 or above), chronic liver disease, or any other severe systemic illness. Current use of medications known to markedly affect autonomic function or HRV, including: Anti-arrhythmic drugs Tricyclic antidepressants or other centrally acting psychotropic drugs (Participants on antihypertensive drugs with stable dosage were not excluded.) Regular practice of yoga, pranayama, meditation, or breath-control techniques within the preceding 3 months. Inability to perform Ujjayi Pranayama due to: Severe nasal obstruction Recent nasal or throat surgery Severe anxiety or panic disorder precipitated by breath regulation Consumption of caffeine, nicotine, or alcohol within 12 hours prior to assessment. Pregnant or lactating women. Presence of any acute illness, infection, or fever within the preceding 7 days. Participation in another interventional clinical trial within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart rate variability Blood pressure Heart rateTimepoint: before the ujjayi pranayama 5 minutes during ujjayi pranayama 5 minutes after the ujjayi pranyama 5 minutes | — |
Secondary
| Measure | Time frame |
|---|---|
| mean arterial pressure rate pressure productTimepoint: before the ujjayi pranayama 5 minutes during ujjayi pranayama 5 minutes after the ujjayi pranyama 5 minutes | — |
Countries
India
Contacts
Public ContactDr Govindan P
SDM College of Naturopathy and Yogic sciences, Ujire,
Outcome results
None listed